RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference
Rhea-AI Summary
RxSight (NASDAQ:RXST), an ophthalmic medical device company focused on customized vision solutions for post-cataract surgery patients, has announced its participation in the upcoming Morgan Stanley Healthcare Conference in New York City.
The company's management team will deliver their presentation on September 8, 2025, at 10:45 AM ET. Investors can access both the live presentation and archived webcast through the company's investor relations website at investors.rxsight.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, RXST declined 1.28%, reflecting a mild negative market reaction. Argus tracked a trough of -2.1% from its starting point during tracking. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $5M from the company's valuation, bringing the market cap to $359M at that time.
Data tracked by StockTitan Argus on the day of publication.
ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Morgan Stanley Healthcare Conference in New York City.
RxSight’s management is scheduled to present on Monday, September 8, 2025, at 7:45 a.m. Pacific Time / 10:45 a.m. Eastern Time. A live and archived webcast of the presentation will be available at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access RxSight's Morgan Stanley Healthcare Conference presentation?
What does RxSight (RXST) company do?
Where is the Morgan Stanley Healthcare Conference 2025 being held?
